Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Might Ring a Bell
View:
Post by Dibah420 on Oct 23, 2022 11:31am

Might Ring a Bell

Interesting piece in the NYTimes about a rich woman, Marlene Engelhorne,  who'd rather be taxed than be a philathropist.

The Engelhorn family’s multibillion-dollar fortune originated with Friedrich Engelhorn, who about 150 years ago in Germany founded BASF, one of the world’s largest chemical companies. Another family company, Boehringer Mannheim, which produced pharmaceuticals and medical diagnostic equipment, was sold to Roche for $11 billion in 1997.
Comment by canasol44 on Oct 24, 2022 1:41am
This post has been removed in accordance with Community Policy
Comment by yureja55 on Oct 31, 2022 12:59am
This post has been removed in accordance with Community Policy